Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: An online tool for evaluating diagnostic and prognostic gene expression biomarkers in bladder cancer

Fig. 1

Screenshot of BC-BET database. The user selects the gene symbol (FGFR3 is shown) from a dropdown list of available genes, and specifies additional parameters for the analysis. Here, class comparisons are quantified by fold change (FC), p-values will be calculated by the non-parametric Wilcoxon Rank-Sum test, and survival analysis will use the Best Available end point (see Construction and Content) and the continuous gene expression value, and treated patients will be included in the survival analysis in the CNUH and DFCI cohorts. The user clicks on Patient Analysis to evaluate the gene

Back to article page